Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986479 · ClinicalTrials.gov registry record · Phase 2
This is a Study to Determine the Antidepressant Effects of AZD6765
A Phase 2 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT00986479 is a Phase 2 study that has completed, run by AstraZeneca. The registered enrollment target is 22 participants.
The verdict
NCT00986479, a Phase 2 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the antidepressant effects of AZD6765 compared to placebo.
Interventions
- DRUG AZD6765
- DRUG Placebo to AZD6765
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00986479
The ClinicalTrials.gov registry entry for NCT00986479 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AZD6765 is the first listed.
NCT00986479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00986479 about?
NCT00986479 is a clinical study titled "This is a Study to Determine the Antidepressant Effects of AZD6765". The purpose of this study is to determine the antidepressant effects of AZD6765 compared to placebo.
What is the current status of trial NCT00986479?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2009-12. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00986479?
The interventions under investigation include: AZD6765 (DRUG), Placebo to AZD6765 (DRUG).
Who is sponsoring clinical trial NCT00986479?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.